Results 51 to 60 of about 149,314 (241)
Percutaneous balloon dilatation for benign hepaticojejunostomy strictures
BACKGROUND: Percutaneous balloon dilatation of biliary tract strictures is generally accepted as a safe and inexpensive procedure. The effectiveness in selected groups of patients remains under discussion.
Gouma, D. J. +11 more
core +1 more source
AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury
Hepatology, EarlyView.
Robert J. Fontana +6 more
wiley +1 more source
Application of balloon dilatation during tunneled cuffed catheter replacement
ObjectiveTo explore the indication of balloon dilatation and the selection of balloon diameter during tunneled cuffed catheter replacement in the presence of fibroblastic sleeve and/or superior vena cava stenosis or occlusion and examine the causes of ...
Hou Xi-bin +4 more
doaj
Background Tracheal stenosis following prolonged intubation is a relatively rare but serious problem. This condition is usually managed by surgical or endoscopic interventions.
Abdallah Nosair +4 more
doaj +1 more source
ABSTRACT Background The resorbable fibrillated scaffold (RFS) is a novel electrospun, polylactide‐based endoluminal scaffold developed for peripheral arterial applications. Its porous microfibre architecture is intended to support host cell infiltration and vascular restoration.
Kotaro Miyashita +16 more
wiley +1 more source
The Evaluation of Endoscopic Balloon Dilation Treatment for Benign Gastric Outlet Obstruction
Balloon dilatation of stricture is one of the new treatment methods among patients with gastric outlet obstruction (GOO). However, the prevalence and underlying etiologies of GOO in various populations are different.
Javad Shokri-Shirvani +4 more
doaj
A comparison of three kinds of balloon dilatations for patients with benign esophageal strictures
Benign esophageal strictures (BES) have been usually treated with balloon dilatation with occasionally drug-coated balloon (DCB) or large balloon dilatation.
Ping Liu +4 more
doaj +1 more source
ABSTRACT Background Evidence regarding the risk‐stratified effectiveness of drug‐coated balloon (DCB)‐based PCI for de novo coronary artery disease (CAD) remains limited, particularly in patients undergoing complex and high‐risk indicated percutaneous coronary intervention (CHIP PCI).
Dong Oh Kang +3 more
wiley +1 more source
Balloon dilatation angioplasty: nonsurgical management of coarctation of the aorta.
Balloon dilatation angioplasty was successfully performed in five patients (ages 18 months to 17 years) with discrete aortic coarctation. The catheter size was No. 8F or 9F.
S B Ritter, R S Cooper, R J Golinko
core +1 more source
ABSTRACT Percutaneous transaxillary access is an established alternative to transfemoral large‐bore arterial access for transcatheter structural heart interventions and mechanical circulatory support (MCS). Although useful for overcoming hostile iliofemoral anatomy and providing prolonged support and patient mobilization in case of MCS, the axillary ...
Gioel Gabrio Secco +9 more
wiley +1 more source

